This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Sinphar Tian-Li Pharmaceutical Co., Ltd. (Hangzhou). Active years: 2016.
Company Filing History:
Years Active: 2016
Title: The Innovations of Muh-Hwan Su
Introduction
Muh-Hwan Su is a notable inventor based in Ilan, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular conditions. His innovative approach combines traditional elements with modern medicine, showcasing the potential of natural extracts in therapeutic applications.
Latest Patents
Muh-Hwan Su holds a patent for a pharmaceutical composition aimed at treating or preventing angina and myocardial infarction induced by myocardial ischemia. The patent describes a combination of tea extract, specifically catechins, and an antianginal drug, which has been proven therapeutically effective. This invention not only addresses the immediate needs of patients suffering from these conditions but also highlights the use of natural ingredients in modern medicine.
Career Highlights
Throughout his career, Muh-Hwan Su has worked with reputable companies, including Sinphar Tian-Li Pharmaceutical Co., Ltd. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that bridge the gap between traditional remedies and contemporary medical practices.
Collaborations
Muh-Hwan Su has collaborated with professionals such as Jing Jing Justine Tang and Hang-Ching Lin. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Muh-Hwan Su's work exemplifies the integration of natural extracts in pharmaceutical compositions, offering promising solutions for cardiovascular health. His contributions to the field are noteworthy and reflect a commitment to innovation in medicine.